Status: Recruiting
The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
To prospectively evaluate the effectiveness and safety of SBRT in the treatment of residual malignant pulmonary nodules after lung cancer, and is committed to providing new treatment options for patients with multiple primary malignant pulmonary nodules who cannot tolerate multiple operations.
Participants needed: 40
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Fang WuUpdated: Nov 28, 2025Locations: 5Duration: 2 Years
Eligibility criteria
Not listed